Vertex Pharmaceuticals Inc. buy BMO Capital Markets
Start price
20.12.24
/
50%
€379.90
Target price
20.12.25
€498.52
Performance (%)
0.08%
Price
10.12.25
€380.20
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc. is nearly unchanged. This prediction currently runs until 20.12.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -4.256% | -4.256% |
| iShares Core DAX® | 1.803% | 0.496% |
| iShares Nasdaq 100 | 0.429% | -0.410% |
| iShares Nikkei 225® | 0.708% | -3.799% |
| iShares S&P 500 | 0.288% | -0.218% |
Comments by BMO_Capital_Markets for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at BMO Capital Markets from $566.00 to $520.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€349.95
05.08.25
05.08.25
€458.50
05.08.26
05.08.26
8.64%
10.12.25
10.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€413.40
31.05.24
31.05.24
€459.80
31.05.25
31.05.25
-6.79%
01.06.25
01.06.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€357.80
07.11.23
07.11.23
€388.11
07.11.24
07.11.24
30.65%
08.11.24
08.11.24
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€327.35
02.08.23
02.08.23
€355.55
02.08.24
02.08.24
35.94%
03.08.24
03.08.24